JASON KIMATA to HIV-1
This is a "connection" page, showing publications JASON KIMATA has written about HIV-1.
Connection Strength
5.464
-
Variable antiviral activity of islatravir against M184I/V mutant HIV-1 selected during antiretroviral therapy. J Antimicrob Chemother. 2024 02 01; 79(2):370-374.
Score: 0.651
-
Engineered CD4 T cells expressing a membrane anchored viral inhibitor restrict HIV-1 through cis and trans mechanisms. Front Immunol. 2023; 14:1167965.
Score: 0.634
-
Glycosyl-Phosphatidylinositol-Anchored Anti-HIV Env Single-Chain Variable Fragments Interfere with HIV-1 Env Processing and Viral Infectivity. J Virol. 2018 04 01; 92(7).
Score: 0.433
-
Subversion of Cell Cycle Regulatory Mechanisms by HIV. Cell Host Microbe. 2015 Jun 10; 17(6):736-40.
Score: 0.358
-
Stepping toward a macaque model of HIV-1 induced AIDS. Viruses. 2014 Sep 25; 6(9):3643-51.
Score: 0.341
-
A variant macaque-tropic human immunodeficiency virus type 1 is resistant to alpha interferon-induced restriction in pig-tailed macaque CD4+ T cells. J Virol. 2013 Jun; 87(12):6678-92.
Score: 0.307
-
Vif substitution enables persistent infection of pig-tailed macaques by human immunodeficiency virus type 1. J Virol. 2011 Apr; 85(8):3767-79.
Score: 0.265
-
Dendritic cell-mediated HIV-1 infection of T cells demonstrates a direct relationship to plasma viral RNA levels. J Acquir Immune Defic Syndr. 2010 Jun; 54(2):115-21.
Score: 0.253
-
ICAM-3 influences human immunodeficiency virus type 1 replication in CD4(+) T cells independent of DC-SIGN-mediated transmission. Virology. 2007 Aug 01; 364(2):383-94.
Score: 0.203
-
Elimination of Human Immunodeficiency Virus Reservoirs Harboring Intact Proviruses. J Infect Dis. 2026 Feb 18; 233(2):267-277.
Score: 0.188
-
HIV-1 fitness and disease progression: insights from the SIV-macaque model. Curr HIV Res. 2006 Jan; 4(1):65-77.
Score: 0.186
-
Optimization of Cellular Transduction by the HIV-Based Pseudovirus Platform with Pan-Coronavirus Spike Proteins. Viruses. 2024 09 20; 16(9).
Score: 0.170
-
HIV-1 subtype F integrase polymorphisms external to the catalytic core domain contribute to severe loss of replication capacity in context of the integrase inhibitor resistance mutation Q148H. J Antimicrob Chemother. 2022 09 30; 77(10):2793-2802.
Score: 0.148
-
Clearance of HIV-1 or SIV reservoirs by promotion of apoptosis and inhibition of autophagy: Targeting intracellular molecules in cure-directed strategies. J Leukoc Biol. 2022 11; 112(5):1245-1259.
Score: 0.143
-
Clearance of HIV infection by selective elimination of host cells capable of producing HIV. Nat Commun. 2020 08 13; 11(1):4051.
Score: 0.128
-
PACS1 is an HIV-1 cofactor that functions in Rev-mediated nuclear export of viral RNA. Virology. 2020 01 15; 540:88-96.
Score: 0.121
-
Distinct susceptibility of HIV vaccine vector-induced CD4 T cells to HIV infection. PLoS Pathog. 2018 02; 14(2):e1006888.
Score: 0.108
-
Efficient Transduction of Human and Rhesus Macaque Primary T Cells by a Modified Human Immunodeficiency Virus Type 1-Based Lentiviral Vector. Hum Gene Ther. 2017 03; 28(3):271-285.
Score: 0.100
-
The Glycosylphosphatidylinositol-Anchored Variable Region of Llama Heavy Chain-Only Antibody JM4 Efficiently Blocks both Cell-Free and T Cell-T Cell Transmission of Human Immunodeficiency Virus Type 1. J Virol. 2016 Dec 01; 90(23):10642-10659.
Score: 0.099
-
Glycosyl Phosphatidylinositol-Anchored C34 Peptide Derived From Human Immunodeficiency Virus Type 1 Gp41 Is a Potent Entry Inhibitor. J Neuroimmune Pharmacol. 2016 09; 11(3):601-10.
Score: 0.095
-
CCR5 gene disruption via lentiviral vectors expressing Cas9 and single guided RNA renders cells resistant to HIV-1 infection. PLoS One. 2014; 9(12):e115987.
Score: 0.087
-
Trimeric glycosylphosphatidylinositol-anchored HCDR3 of broadly neutralizing antibody PG16 is a potent HIV-1 entry inhibitor. J Virol. 2013 Feb; 87(3):1899-905.
Score: 0.075
-
Potent and broad anti-HIV-1 activity exhibited by a glycosyl-phosphatidylinositol-anchored peptide derived from the CDR H3 of broadly neutralizing antibody PG16. J Virol. 2011 Sep; 85(17):8467-76.
Score: 0.068
-
GPI-anchored single chain Fv--an effective way to capture transiently-exposed neutralization epitopes on HIV-1 envelope spike. Retrovirology. 2010 Oct 06; 7:79.
Score: 0.065
-
Suppression of viremia and evolution of human immunodeficiency virus type 1 drug resistance in a macaque model for antiretroviral therapy. J Virol. 2007 Nov; 81(22):12145-55.
Score: 0.052
-
A nonneutralizing anti-HIV Type 1 antibody turns into a broad neutralizing antibody when expressed on the surface of HIV type 1-susceptible cells. II. Inhibition of HIV type 1 captured and transferred by DC-SIGN. AIDS Res Hum Retroviruses. 2006 Sep; 22(9):874-83.
Score: 0.049
-
Integration of human immunodeficiency virus type 1 in untreated infection occurs preferentially within genes. J Virol. 2006 Aug; 80(15):7765-8.
Score: 0.048
-
Capture and transfer of simian immunodeficiency virus by macaque dendritic cells is enhanced by DC-SIGN. J Virol. 2002 Dec; 76(23):11827-36.
Score: 0.038
-
Timing of Antiretroviral Therapy Initiation Determines Rectal Natural Killer Cell Populations. AIDS Res Hum Retroviruses. 2020 04; 36(4):314-323.
Score: 0.031
-
Replication of human immunodeficiency virus 1 and Moloney murine leukemia virus is inhibited by different heteroatom-containing analogs of myristic acid. Proc Natl Acad Sci U S A. 1989 Nov; 86(22):8655-9.
Score: 0.015
-
Progression to AIDS in macaques is associated with changes in the replication, tropism, and cytopathic properties of the simian immunodeficiency virus variant population. Virology. 1995 Mar 10; 207(2):528-42.
Score: 0.005